Cargando…

Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial

Objective: To compare the anesthetic action of 0.5% bupivacaine in relation to 4% articaine, both with 1:200,000 epinephrine, in the surgical removal of lower third molars. As a secondary objective hemodynamic changes using both anesthetics were analyzed. Study Design: Triple-blind crossover randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sancho-Puchades, Manuel, Vílchez-Pérez, Miguel A., Valmaseda-Castellón, Eduard, Paredes-García, Jordi, Berini-Aytés, Leonardo, Gay-Escoda, Cosme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476102/
https://www.ncbi.nlm.nih.gov/pubmed/22143739
http://dx.doi.org/10.4317/medoral.17628
_version_ 1782247046087966720
author Sancho-Puchades, Manuel
Vílchez-Pérez, Miguel A.
Valmaseda-Castellón, Eduard
Paredes-García, Jordi
Berini-Aytés, Leonardo
Gay-Escoda, Cosme
author_facet Sancho-Puchades, Manuel
Vílchez-Pérez, Miguel A.
Valmaseda-Castellón, Eduard
Paredes-García, Jordi
Berini-Aytés, Leonardo
Gay-Escoda, Cosme
author_sort Sancho-Puchades, Manuel
collection PubMed
description Objective: To compare the anesthetic action of 0.5% bupivacaine in relation to 4% articaine, both with 1:200,000 epinephrine, in the surgical removal of lower third molars. As a secondary objective hemodynamic changes using both anesthetics were analyzed. Study Design: Triple-blind crossover randomized clinical trial. Eighteen patients underwent bilateral removal of impacted lower third molars using 0.5% bupivacaine or 4% articaine in two different appointments. Preoperative, intraoperative and postoperative variables were recorded. Differences were assessed with McNemar tests and repeated measures ANOVA tests. Results: Both solutions exhibited similar latency times and intraoperative efficacy. Statistical significant lower pain levels were observed with bupivacaine between the fifth (p=0.011) and the ninth (p=0.007) postoperative hours. Bupivacaine provided significantly longer lasting soft tissue anesthesia (p<0.05). Systolic blood pressure and heart rate values were significantly higher with articaine. Conclusions: Bupivacaine could be a valid alternative to articaine especially due to its early postoperative pain prevention ability. Key words:Bupivacaine, articaine, third molar, anesthesia, postoperative pain.
format Online
Article
Text
id pubmed-3476102
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-34761022012-10-19 Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial Sancho-Puchades, Manuel Vílchez-Pérez, Miguel A. Valmaseda-Castellón, Eduard Paredes-García, Jordi Berini-Aytés, Leonardo Gay-Escoda, Cosme Med Oral Patol Oral Cir Bucal Research-Article Objective: To compare the anesthetic action of 0.5% bupivacaine in relation to 4% articaine, both with 1:200,000 epinephrine, in the surgical removal of lower third molars. As a secondary objective hemodynamic changes using both anesthetics were analyzed. Study Design: Triple-blind crossover randomized clinical trial. Eighteen patients underwent bilateral removal of impacted lower third molars using 0.5% bupivacaine or 4% articaine in two different appointments. Preoperative, intraoperative and postoperative variables were recorded. Differences were assessed with McNemar tests and repeated measures ANOVA tests. Results: Both solutions exhibited similar latency times and intraoperative efficacy. Statistical significant lower pain levels were observed with bupivacaine between the fifth (p=0.011) and the ninth (p=0.007) postoperative hours. Bupivacaine provided significantly longer lasting soft tissue anesthesia (p<0.05). Systolic blood pressure and heart rate values were significantly higher with articaine. Conclusions: Bupivacaine could be a valid alternative to articaine especially due to its early postoperative pain prevention ability. Key words:Bupivacaine, articaine, third molar, anesthesia, postoperative pain. Medicina Oral S.L. 2012-05 2011-12-06 /pmc/articles/PMC3476102/ /pubmed/22143739 http://dx.doi.org/10.4317/medoral.17628 Text en Copyright: © 2012 Medicina Oral S.L. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research-Article
Sancho-Puchades, Manuel
Vílchez-Pérez, Miguel A.
Valmaseda-Castellón, Eduard
Paredes-García, Jordi
Berini-Aytés, Leonardo
Gay-Escoda, Cosme
Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial
title Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial
title_full Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial
title_fullStr Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial
title_full_unstemmed Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial
title_short Bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. A crossover randomized controlled trial
title_sort bupivacaine 0.5 % versus articaine 4 % for the removal of lower third molars. a crossover randomized controlled trial
topic Research-Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476102/
https://www.ncbi.nlm.nih.gov/pubmed/22143739
http://dx.doi.org/10.4317/medoral.17628
work_keys_str_mv AT sanchopuchadesmanuel bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial
AT vilchezperezmiguela bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial
AT valmasedacastelloneduard bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial
AT paredesgarciajordi bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial
AT beriniaytesleonardo bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial
AT gayescodacosme bupivacaine05versusarticaine4fortheremovaloflowerthirdmolarsacrossoverrandomizedcontrolledtrial